|
Market Cap (2-Jul) $363,897,504 (530th) |
Close (30-Jun) $0.315 |
Volume (30-Jun) 2,012,212 |
Shortsold (19-Jun) 27,150,697 (1.86%) (138th) |
|
52w High $0.415 |
52w Low $0.223 |
P/E 7.50 |
EPS -0.03 |
IMM released this announcement to the ASX on 23 February 2022, 18:22. The announcement is marked as price sensitive, and is 30 page(s) in length and 479.99kb in size.
You can view all announcements from IMM and see how they appear on a price chart on the announcements page.
At the date of this announcement, IMM was 1.161% short sold according to ASIC data. It was ranked the 171st most shorted stock on the ASX. It is now ranked as the 138th most shorted stock on the ASX with 1.859% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from IMM | |
|---|---|
| Application for quotation of securities - IMM | 29 June 2023, 10:09 |
| US patent granted for Efti with PD-1 pathway inhibitor | 27 June 2023, 14:37 |
| Immutep completes underwritten retail entitlement offer | 27 June 2023, 8:16 |
| Half Yearly Report and Accounts | 23 February 2022, 18:22 |
| Immutep to present new data from TACTI-002 at ELCC 2022 | 18 February 2022, 8:13 |
| Immutep Investor Update | 18 February 2022, 8:11 |
| Australian Patent Granted for Efti with PD-1 Inhibitors | 11 February 2022, 11:58 |
You must be logged in to post a reply.
